203 related articles for article (PubMed ID: 35577640)
1. HPV Vaccination: Does It Have a Role in Preventing Penile Cancer and Other Preneoplastic Lesions?
Elst L; Albersen M
Semin Oncol Nurs; 2022 Jun; 38(3):151284. PubMed ID: 35577640
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A
Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus-related disease in men: not just a women's issue.
Palefsky JM
J Adolesc Health; 2010 Apr; 46(4 Suppl):S12-9. PubMed ID: 20307839
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus vaccination and prevention of intraepithelial neoplasia and penile cancer: review article.
da Costa Nunes JF; Pires S; Chade DC
Curr Opin Urol; 2020 Mar; 30(2):208-212. PubMed ID: 31972636
[TBL] [Abstract][Full Text] [Related]
5. [The disease burden of human papillomavirus in men is substantial and can potentially be prevented].
Kiellberg Larsen H; Kofoed K; Sand C
Ugeskr Laeger; 2013 Feb; 175(6):349-53. PubMed ID: 23402241
[TBL] [Abstract][Full Text] [Related]
6. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.
Marty R; Roze S; Bresse X; Largeron N; Smith-Palmer J
BMC Cancer; 2013 Jan; 13():10. PubMed ID: 23298365
[TBL] [Abstract][Full Text] [Related]
7. The Role of Human Papilloma Virus in Penile Carcinogenesis and Preneoplastic Lesions: A Potential Target for Vaccination and Treatment Strategies.
Diorio GJ; Giuliano AR
Urol Clin North Am; 2016 Nov; 43(4):419-425. PubMed ID: 27717428
[TBL] [Abstract][Full Text] [Related]
8. Genital HPV infection and related lesions in men.
Anic GM; Giuliano AR
Prev Med; 2011 Oct; 53 Suppl 1(Suppl 1):S36-41. PubMed ID: 21962470
[TBL] [Abstract][Full Text] [Related]
9. Acceptability of HPV vaccines and perceptions related to genital warts and penile/anal cancers among men who have sex with men in Hong Kong.
Wang Z; Mo PK; Lau JT; Lau M; Lai CH
Vaccine; 2013 Sep; 31(41):4675-81. PubMed ID: 23845815
[TBL] [Abstract][Full Text] [Related]
10. Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study.
Sudenga SL; Ingles DJ; Pierce Campbell CM; Lin HY; Fulp WJ; Messina JL; Stoler MH; Abrahamsen M; Villa LL; Lazcano-Ponce E; Giuliano AR
Eur Urol; 2016 Jan; 69(1):166-73. PubMed ID: 26051441
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Dec; 31 Suppl 5():F1-31. PubMed ID: 24331745
[TBL] [Abstract][Full Text] [Related]
12. [The first vaccine against cancer: the human papillomavirus vaccine].
Bősze P
Orv Hetil; 2013 Apr; 154(16):603-18. PubMed ID: 23587540
[TBL] [Abstract][Full Text] [Related]
13. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
Arbyn M; de Sanjosé S; Saraiya M; Sideri M; Palefsky J; Lacey C; Gillison M; Bruni L; Ronco G; Wentzensen N; Brotherton J; Qiao YL; Denny L; Bornstein J; Abramowitz L; Giuliano A; Tommasino M; Monsonego J
Int J Cancer; 2012 Nov; 131(9):1969-82. PubMed ID: 22623137
[TBL] [Abstract][Full Text] [Related]
14. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
Sehnal B; Vojáčková N; Driák D; Kmoníčková E; Vaňousová D; Maxová K; Neumannová H; Sláma J
Klin Onkol; 2014; 27(4):239-46. PubMed ID: 25115712
[TBL] [Abstract][Full Text] [Related]
15. [The importance of HPV vaccination in men].
Sehnal B; Chlíbek R; Sláma J
Cas Lek Cesk; 2016; 155(4):34-9. PubMed ID: 27481200
[TBL] [Abstract][Full Text] [Related]
16. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
Lurie S; Mizrachi Y; Chodick G; Katz R; Schejter E
Gynecol Oncol; 2017 Aug; 146(2):299-304. PubMed ID: 28602548
[TBL] [Abstract][Full Text] [Related]
17. Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?
McRee AL; Reiter PL; Chantala K; Brewer NT
Cancer Epidemiol Biomarkers Prev; 2010 Aug; 19(8):1937-44. PubMed ID: 20647398
[TBL] [Abstract][Full Text] [Related]
18. Cancer Prevention Begins in Middle School: The Personal Advantages of HPV Immunization in Males.
Gordon J; Bail J
NASN Sch Nurse; 2023 May; 38(3):114-120. PubMed ID: 36691362
[TBL] [Abstract][Full Text] [Related]
19. From the monovalent to the nine-valent HPV vaccine.
Pils S; Joura EA
Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
[TBL] [Abstract][Full Text] [Related]
20. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
Pitisuttithum P; Velicer C; Luxembourg A
Expert Rev Vaccines; 2015; 14(11):1405-19. PubMed ID: 26366475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
